This firm fixed-price purchase order was awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The $237,668.88 contract is for the continuation of service and maintenance on three 7500 FAST DX real-time PCR instruments used by the Naval Medical Research Command's Molecular Diagnostics Department. As the original equipment manufacturer, Life Technologies was determined to be the only source capable of servicing this specialized equipment without compromising performance or warranties. The contract has a base year (FY2025-FY2026) with four one-year option periods, and was awarded on a sole source basis with no set-aside. Life Technologies has previously supported federal agencies, including the NIH, DoD, USDA, and DOJ, through prime contracts and subcontracts for a range of biotechnology products and services.
Generated 3/11/25, 9:58 AM